4503

Astellas Pharma
4503

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥2.89T
EV
¥3.34T
Shares Outstanding
1.79B
Beta
0.04
Industry
Drug Manufacturers - General

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
14
P/E 2026E
19.18x
P/Revenue 2026E
1.45x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Astellas Pharma Inc.

gainify
4503

Astellas Pharma Inc.

4503

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia wit...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Okamura, Naoki

Employees

13,643

IPO Date

2000-01-04

Headquarters

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.